SecBot SecBot
8-K ·Filed May 8, 2026

CCEL

CRYO CELL INTERNATIONAL INC
NEUTRAL
Impact 4/10
Horizonmonths Processed5mo ago SEC0001193125-26-214569
8-K context-dependent: Items 3.01, 7.01
Actionable Insight • Neutral

Monitor Cryo-Cell's quarterly filings for progress on regaining compliance; failure to meet plan milestones could trigger delisting proceedings.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
CCEL ▲ +3.41% at T+60d
NEUTRAL call +3.41% · α vs SPY -0.98% · entry $3.52 → $3.64
Entry = T+0 close
May 8, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.14%
$3.52
settled 6mo ago
T+5d
+0.85%
call +0.85% · α +0.94%
$3.55
settled 6mo ago
T+20d
-1.99%
call -1.99% · α -1.68%
$3.45
settled 5mo ago
T+60d
+3.41%
call +3.41% · α -0.98%
$3.64
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Cryo-Cell International received acceptance of its compliance plan from NYSE American, avoiding immediate delisting and extending the compliance period through September 9, 2027. The stock will continue trading while the company works to address stockholders' deficit and net losses.

Key Facts

  • NYSE American accepted Cryo-Cell's compliance plan on May 6, 2026.
  • Compliance plan period extends through September 9, 2027.
  • Non-compliance was due to stockholders' deficit and net losses in two of the last three fiscal years.
  • Common stock remains listed and traded on NYSE American during the plan period.

Financial Impact

No financial figures provided; delisting risk alleviated for now.

Risk Factors

  • Failure to regain compliance by September 9, 2027 could lead to delisting.
  • If the company fails to make progress consistent with the plan, NYSE American may initiate delisting proceedings earlier.

Market Snapshot

Exchange
NYSE
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-214569
Document: ccel-ex99_1.htm0001193125-26-214569
Document: 0001193125-26-214569-index-headers.html0001193125-26-214569
Document: 0001193125-26-214569-index.html0001193125-26-214569
Document: 0001193125-26-214569.txt0001193125-26-214569
2 reports for CCEL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CCEL — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
DEF 14A
BEARISH ★ 5/10
$4.15 $4.68▼ −12.77%▼ −12.31%$4.97 (−19.71%)
May 8, 2026
24w ago
8-K
NEUTRAL ★ 4/10
$3.52 $3.55▲ +0.85%▲ +0.94%$4.97 (+41.14%)
Showing 2 of 2

US Market Status

Market Open — Closes in 1h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 8, 2026